Multicenter, Prospective, Real World Study of Camrelizumab in Cross-line Treatment of Non-small Cell Lung Cancer
Clinical trial NCT05547737 · UNKNOWN
Trial details
- NCT number
- NCT05547737
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-21
- Primary completion
- 2025-09-21
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.